We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Short Telomere Length Linked to Increased Risk of Heart Disease, Early Death

By LabMedica International staff writers
Posted on 29 Feb 2012
Analysis of data collected during two large prospective studies revealed that short telomere length – an indication of advanced cellular age - was associated with increased risk of myocardial infarction, ischemic heart disease, and early death. More...


Investigators at the University of Copenhagen (Denmark) measured telomere length in leukocytes from the 19,838 Danish participants in the Copenhagen City Heart Study and the Copenhagen General Population Study. Participants were followed for up to 19 years for incidents of myocardial infarction (929 cases), ischemic heart disease (2038 cases), and death (4342 cases).

Results published in the March 2012 online edition of the journal Arteriosclerosis, Thrombosis and Vascular Biology revealed that telomere length decreased linearly with increasing age in women and men in both studies. Hazard ratios were calculated as being 1.10 for myocardial infarction, 1.06 for ischemic heart disease, and 1.09 for early death per 1000–base pair decrease in telomere length. The difference in risk between those with shortest telomere length and those with longest telomere length was 50% for heart attack and 25% for early death.

“The risk of heart attack or early death is present whether your telomeres are shortened due to lifestyle or due to high age,” said senior author Dr. Borge Nordestgaard, professor of genetic epidemiology at the University of Copenhagen. “That smoking and obesity increases the risk of heart disease has been known for a while. We have now shown, as has been speculated, that the increased risk is directly related to the shortening of the protective telomeres - so you can say that smoking and obesity ages the body on a cellular level, just as surely as the passing of time.”

“Future studies will have to reveal the actual molecular mechanism by which the short telomere length causes heart attacks,” said Dr. Nordestgaard. “Does one cause the other or is the telomere length and the coronary event both indicative of a third - yet unknown - mechanism?”

Related Links:

University of Copenhagen



Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Blood Ammonia Test Analyzer
DRI-CHEM NX10N
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.